Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03112174
Title Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (SYMPATICO)
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Pharmacyclics LLC.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | TUR | POL | NLD | ITA | HUN | GRC | GBR | FRA | ESP | DEU | CZE | CAN | BEL | AUS


No variant requirements are available.